CRXTW - Clarus Therapeutics Holdings Inc. (CRXT) CEO Bob Dudley on Q1 2022 Results - Earnings Call Transcript
Clarus Therapeutics Holdings, Inc. (CRXT) Q1 2022 Earnings Conference Call May 16, 2022, 05:15 PM ET Company Participants Bob Dudley - Founder, President and CEO Ric Peterson - CFO Frank Jaeger - Chief Commercial Officer Conference Call Participants Presentation Operator Thank you for joining in the Clarus First Quarter 2022 Financial and Operating Results Conference Call. Today's call is being recorded and webcast live on the company's website at www.clarustherapeutics.com in the Investor Relations section, and it will be available for replay for 10 days following this live call. Please note that discussions today may include forward-looking statements. These forward-looking statements include statements regarding the market opportunity for JATENZO, the anticipated benefits of recent patient initiatives, and statements regarding the Clarus growth strategy, it's pipeline and IP portfolio among others. Forward-looking statements involve a number of risks, uncertainties, some of which are beyond Clarus control. Our other assumptions that may
For further details see:
Clarus Therapeutics Holdings, Inc. (CRXT) CEO Bob Dudley on Q1 2022 Results - Earnings Call Transcript